Connect with us

Health

Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference

Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.

Published

on

Article feature image
ADVERTISEMENT

The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending